Company / SG&A Expense
Citius Pharmaceuticals, Inc. SG&A Expense History
FY2011-FY2013 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$690.4K
FY2013
5-year range
$4.1K / $690.4K
FY2011-FY2013
Trend
+16909.0%
vs FY2012
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense changed +16909% YoY in FY2013, a notable deviation from the 2-year average annual change of +8421%.
Based on SEC 10-K filings.
$690,396 in FY2013.
Increased from $12,187 to $690,396 over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2013, sg&a expense increased 16909.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2013 | $690.4K | +16909.0% |
| FY2012 | $4.1K | -66.7% |
| FY2011 | $12.2K | - |
As of FY2013 · SEC 10-K · Updated Jun 22, 2026